South Dakota Investment Council Sells 14,249 Shares of Encompass Health Corporation $EHC

South Dakota Investment Council trimmed its position in shares of Encompass Health Corporation (NYSE:EHC) by 20.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,582 shares of the company’s stock after selling 14,249 shares during the quarter. South Dakota Investment Council’s holdings in Encompass Health were worth $6,933,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Level Four Advisory Services LLC lifted its position in shares of Encompass Health by 9.8% during the third quarter. Level Four Advisory Services LLC now owns 11,013 shares of the company’s stock valued at $1,399,000 after purchasing an additional 983 shares in the last quarter. Focus Partners Advisor Solutions LLC lifted its position in shares of Encompass Health by 61.7% during the 3rd quarter. Focus Partners Advisor Solutions LLC now owns 2,803 shares of the company’s stock worth $329,000 after buying an additional 1,070 shares in the last quarter. Elo Mutual Pension Insurance Co purchased a new position in shares of Encompass Health in the 3rd quarter worth approximately $1,531,000. Bahl & Gaynor Inc. grew its holdings in shares of Encompass Health by 46.3% in the third quarter. Bahl & Gaynor Inc. now owns 421,811 shares of the company’s stock valued at $53,578,000 after acquiring an additional 133,585 shares in the last quarter. Finally, Brand Asset Management Group Inc. bought a new stake in Encompass Health during the third quarter worth $242,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Insider Activity

In related news, CEO Mark J. Tarr sold 150,000 shares of the business’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the sale, the chief executive officer directly owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Barclays raised their price objective on shares of Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Finally, Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average price target of $143.29.

Encompass Health Price Performance

NYSE EHC opened at $107.94 on Wednesday. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.76. The company has a market cap of $10.73 billion, a PE ratio of 19.48, a price-to-earnings-growth ratio of 2.07 and a beta of 0.71. Encompass Health Corporation has a 52 week low of $92.53 and a 52 week high of $127.99. The firm’s 50-day simple moving average is $103.89 and its two-hundred day simple moving average is $113.88.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.29 by $0.17. The company had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.17 earnings per share. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 13.72%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.